1. Home
  2. Stock quotes
  3. Regeneron Pharmaceuticals
  4. Financial Statements
  5. Cash Flow
  6. Accounts Payables
Regeneron Pharmaceuticals logo
Regeneron Pharmaceuticals REGN
$ 704.47 -0.53%
mail-toReport an Error

Quarterly report 2024-Q3
added 10-31-2024

report update icon

Regeneron Pharmaceuticals Accounts Payables 2011-2024 | REGN

Annual Accounts Payables Regeneron Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
607 M 589 M 564 M 476 M 418 M 218 M - 135 M 141 M 99.5 M 61.9 M 38.9 M 27.7 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
607 M 27.7 M 281 M

Quarterly Accounts Payables Regeneron Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
497 M 562 M 671 M 537 M 547 M 600 M 589 M - - - 564 M - - - 476 M - - - 418 M - - - 218 M - - - 178 M 154 M 151 M 142 M 135 M 135 M 135 M 135 M 141 M 141 M 141 M 141 M 99.5 M 99.5 M 99.5 M 99.5 M 61.9 M 61.9 M 61.9 M 61.9 M 38.9 M 38.9 M 38.9 M 38.9 M 27.7 M 27.7 M 27.7 M 27.7 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
671 M 27.7 M 213 M